Research statistics
GHRP-6 research: publications and trials
At a glance
Publications, all years
412
Since 1988
Publications in 2026 so far
8
Through November 15, 2026
Human clinical research
21.1%
87 of 412 classified
Registered clinical trials
0
ClinicalTrials.gov
Randomized controlled trials
17
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
73.8%
236 animal · 65 in vitro · 3 computational
Records that only mention it
297
Not counted above
Status in the library: Research only. Groups: Growth hormone axis.
What to keep in mind
- More than 70% of the indexed publications are animal, cell or computational studies.
Publications by year
GHRP-6 publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1988 | 0 | 1 | 0 | 0 | 1 |
| 1989 | 0 | 2 | 0 | 0 | 2 |
| 1990 | 0 | 2 | 0 | 0 | 2 |
| 1991 | 0 | 5 | 0 | 0 | 5 |
| 1992 | 0 | 2 | 0 | 0 | 2 |
| 1993 | 5 | 4 | 3 | 0 | 12 |
| 1994 | 4 | 7 | 0 | 0 | 11 |
| 1995 | 9 | 11 | 0 | 0 | 20 |
| 1996 | 6 | 8 | 4 | 0 | 18 |
| 1997 | 4 | 11 | 3 | 0 | 18 |
| 1998 | 6 | 10 | 3 | 0 | 19 |
| 1999 | 3 | 8 | 1 | 0 | 12 |
| 2000 | 2 | 7 | 1 | 0 | 10 |
| 2001 | 4 | 8 | 0 | 0 | 12 |
| 2002 | 6 | 5 | 0 | 0 | 11 |
| 2003 | 8 | 6 | 0 | 0 | 14 |
| 2004 | 4 | 7 | 0 | 0 | 11 |
| 2005 | 1 | 9 | 0 | 0 | 10 |
| 2006 | 4 | 7 | 0 | 0 | 11 |
| 2007 | 5 | 10 | 0 | 0 | 15 |
| 2008 | 3 | 10 | 0 | 0 | 13 |
| 2009 | 5 | 10 | 0 | 0 | 15 |
| 2010 | 3 | 10 | 0 | 0 | 13 |
| 2011 | 0 | 19 | 1 | 0 | 20 |
| 2012 | 1 | 12 | 0 | 0 | 13 |
| 2013 | 0 | 11 | 0 | 1 | 12 |
| 2014 | 0 | 17 | 0 | 0 | 17 |
| 2015 | 1 | 10 | 0 | 0 | 11 |
| 2016 | 0 | 8 | 0 | 0 | 8 |
| 2017 | 1 | 7 | 0 | 0 | 8 |
| 2018 | 0 | 6 | 0 | 1 | 7 |
| 2019 | 0 | 6 | 0 | 0 | 6 |
| 2020 | 0 | 10 | 2 | 0 | 12 |
| 2021 | 0 | 8 | 0 | 0 | 8 |
| 2022 | 0 | 7 | 0 | 0 | 7 |
| 2023 | 0 | 5 | 0 | 0 | 5 |
| 2024 | 1 | 4 | 0 | 0 | 5 |
| 2025 | 0 | 8 | 0 | 0 | 8 |
| 2026 (to date) | 1 | 6 | 1 | 0 | 8 |
Study types
| Animal study | 236 |
|---|---|
| In vitro study | 65 |
| Other clinical trial | 58 |
| Review | 19 |
| Randomized controlled trial | 17 |
| Observational human study | 9 |
| Case report | 3 |
| Computational study | 3 |
| Editorial, letter or other | 2 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Endocrinology | 195 |
|---|---|
| Neurological and mental health | 147 |
| Metabolic health | 60 |
| Obesity and weight management | 41 |
| Cardiovascular | 28 |
| Gastrointestinal | 26 |
| Musculoskeletal | 23 |
| Oncology | 23 |
| Immune system | 21 |
| Longevity and aging | 17 |
| Cognitive health | 16 |
| Reproductive and sexual health | 15 |
Registered clinical trials
A registration is not a result.
No registered trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · July 16, 2026 · Randomized controlled trial · cited 0 times
PMID 42462342 · DOI 10.1016/j.jocn.2026.112195 · Human clinical research
- Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial.
Frontiers in neurology · April 4, 2024 · Randomized controlled trial · cited 6 times · open access
PMID 38638315 · DOI 10.3389/fneur.2024.1303402 · Human clinical research
- Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
Metabolism: clinical and experimental · March 1, 2010 · Randomized controlled trial · cited 8 times · open access
PMID 20189610 · DOI 10.1016/j.metabol.2010.01.021 · Human clinical research
- Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
Clinical endocrinology · April 29, 2009 · Randomized controlled trial · cited 9 times
PMID 19453623 · DOI 10.1111/j.1365-2265.2009.03618.x · Human clinical research
- Decreased ghrelin-induced GH release in thyrotoxicosis: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
Pituitary · January 1, 2007 · Randomized controlled trial · cited 6 times
PMID 17410412 · DOI 10.1007/s11102-007-0005-2 · Human clinical research
- GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP.
Journal of endocrinological investigation · March 1, 2003 · Randomized controlled trial · cited 13 times
PMID 12809173 · DOI 10.1007/bf03345162 · Human clinical research
- Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
Molecular and cellular endocrinology · November 1, 2002 · Randomized controlled trial · cited 17 times
PMID 12431802 · DOI 10.1016/s0303-7207(02)00293-9 · Human clinical research
- Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
Clinical endocrinology · October 1, 2001 · Randomized controlled trial · cited 12 times
PMID 11678828 · DOI 10.1046/j.1365-2265.2001.01374.x · Human clinical research
- Acute dexamethasone administration enhances GH responsiveness to GH releasing peptide-6 (GHRP-6) in man.
Clinical endocrinology · October 1, 1999 · Randomized controlled trial · cited 8 times · open access
PMID 10583306 · DOI 10.1046/j.1365-2265.1999.00792.x · Human clinical research
- Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
Metabolism: clinical and experimental · April 1, 1999 · Randomized controlled trial · cited 14 times
PMID 10206449 · DOI 10.1016/s0026-0495(99)90115-4 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.
Endocrinology · January 1, 2002 · Animal study · cited 436 times
PMID 11751604 · DOI 10.1210/endo.143.1.8561 · Animal studies
- Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats.
Journal of neuroendocrinology · November 1, 2000 · Animal study · cited 354 times
PMID 11069119 · DOI 10.1046/j.1365-2826.2000.00584.x · Animal studies
- Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6.
Endocrinology · February 1, 1997 · Animal study · cited 304 times · open access
PMID 9003014 · DOI 10.1210/endo.138.2.4907 · Animal studies
- The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.
Endocrinology · June 1, 1989 · Animal study · cited 297 times
PMID 2541999 · DOI 10.1210/endo-124-6-2791 · Animal studies
- Identification of a new G-protein-linked receptor for growth hormone secretagogues.
Molecular endocrinology (Baltimore, Md.) · January 1, 1996 · Animal study · cited 204 times · open access
PMID 8838145 · DOI 10.1210/mend.10.1.8838145 · Animal studies
Latest publications
- Ghrelin attenuates hypoxia-induced mitochondrial oxidative stress damage in HTR-8/SVneo trophoblasts.
Tissue & cell · September 10, 2026 · In vitro study · cited 0 times · open access
PMID 42753464 · DOI 10.1016/j.tice.2026.103950 · In vitro studies
- Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · July 16, 2026 · Randomized controlled trial · cited 0 times
PMID 42462342 · DOI 10.1016/j.jocn.2026.112195 · Human clinical research
- EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences.
Neurotoxicity research · July 4, 2026 · Animal study · cited 0 times
PMID 42399524 · DOI 10.1007/s12640-026-00807-0 · Animal studies
- Ghrelin impairs embryo development after ovarian hyperstimulation.
The Journal of endocrinology · July 1, 2026 · Animal study · cited 0 times
PMID 42461148 · DOI 10.1530/joe-26-0041 · Animal studies
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Frontiers in endocrinology · June 18, 2026 · Review · cited 1 times · open access
PMID 42395176 · DOI 10.3389/fendo.2026.1822475 · Reviews and meta-analyses
- A discovery-based proteomic approach of epidermal growth factor and growth hormone-releasing peptide-6 in a model of acute ischemic stroke.
Pharmacological reports : PR · June 8, 2026 · Animal study · cited 0 times
PMID 42258095 · DOI 10.1007/s43440-026-00872-4 · Animal studies
- Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.
Pharmaceuticals (Basel, Switzerland) · March 12, 2026 · Animal study · cited 0 times · open access
PMID 41901314 · DOI 10.3390/ph19030468 · Animal studies
- Growth hormone releasing peptide-6 (GHRP-6) ameliorates acute lung injury and its subsequent evolvement to interstitial fibrosis.
International immunopharmacology · January 13, 2026 · Animal study · cited 0 times
PMID 41534456 · DOI 10.1016/j.intimp.2026.116204 · Animal studies
- Effect of intracerebroventricular (ICV) injection of antimicrobial peptide expressed in the body-2 (LEAP-2) and its interaction with cannabinoid and ghrelin systems on food intake in broiler chickens.
Poultry science · December 6, 2025 · Animal study · cited 1 times · open access
PMID 41406822 · DOI 10.1016/j.psj.2025.106199 · Animal studies
- Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation.
Journal of nanobiotechnology · December 1, 2025 · Animal study · cited 2 times · open access
PMID 41327290 · DOI 10.1186/s12951-025-03888-9 · Animal studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: GHRP-6; Growth hormone-releasing peptide-6
((TITLE_ABS:"GHRP-6" OR CHEM:"GHRP-6" OR TITLE_ABS:"GHRP6" OR CHEM:"GHRP6") OR (TITLE_ABS:"Growth hormone-releasing peptide-6" OR CHEM:"Growth hormone-releasing peptide-6" OR TITLE_ABS:"Growth hormone-releasing peptide6" OR CHEM:"Growth hormone-releasing peptide6")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). GHRP-6 research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/ghrp-6